SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vasomedical Inc.
VASO 0.162-6.1%10:37 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Preston Lurie who wrote (441)6/20/1997 11:26:00 AM
From: Victor Cassella   of 1605
 
This is one of the problem that ny broker had with the Mang. of VASO, the internet know more about these little articles before the bus. world.

Friday June 20 10:28 AM EDT

Company Press Release

Georgia PPO to offer EECP

Agreement to provide EECP to Georgians

WESTBURY, N.Y.--(BW HealthWire)--June 20, 1997--Vasomedical, Inc. (NASDAQ:VASO), is pleased to
announce that HealthCorp of America, a provider of EECP(R), has recently entered into an agreement with
Provider Networks of America (Pro-Net), a national Preferred Provider Organization (PPO), to provide
EECP(R) to its participants in Georgia.

Donald Caton, Director of Managed Care for HealthCorp of America, stated ``Pro-Net, one of the largest
networks in Georgia with 5,000 providers, has selected HealthCorp's EECP(R) Advanced Medical Treatment
Center as one of the first facilities contracted to provide outpatient cardiology services on behalf of its covered
members. HealthCorp is an Atlanta-based health care provider that has plans for 37 noninvasive outpatient
centers utilizing EECP(R), among other treatments, to be opened in major cities in the Southeast.''

EECP(R) currently is provided at over twenty treatment centers, hospitals and clinics throughout the country.
Vasomedical, Inc. provides equipment, staff training, and treatment guidelines for EECP(R).

Vasomedical is a medical technology company devoted to the development, manufacture and commercialization
of innovative and cost-effective cardiovascular products.

Contact:

Natalie Karp
516/997-4600, ext.776
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext